ZA200806362B - Recombinant polyclonal antibody for treatment of respiratory syncytial virus infections - Google Patents
Recombinant polyclonal antibody for treatment of respiratory syncytial virus infectionsInfo
- Publication number
- ZA200806362B ZA200806362B ZA200806362A ZA200806362A ZA200806362B ZA 200806362 B ZA200806362 B ZA 200806362B ZA 200806362 A ZA200806362 A ZA 200806362A ZA 200806362 A ZA200806362 A ZA 200806362A ZA 200806362 B ZA200806362 B ZA 200806362B
- Authority
- ZA
- South Africa
- Prior art keywords
- treatment
- polyclonal antibody
- respiratory syncytial
- syncytial virus
- virus infections
- Prior art date
Links
- 206010061603 Respiratory syncytial virus infection Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1027—Paramyxoviridae, e.g. respiratory syncytial virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- A61K2039/507—Comprising a combination of two or more separate antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200600324 | 2006-03-06 | ||
US87471606P | 2006-12-14 | 2006-12-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200806362B true ZA200806362B (en) | 2009-05-27 |
Family
ID=38230163
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200806362A ZA200806362B (en) | 2006-03-06 | 2008-07-22 | Recombinant polyclonal antibody for treatment of respiratory syncytial virus infections |
Country Status (12)
Country | Link |
---|---|
US (1) | US20100040606A1 (ko) |
EP (1) | EP2004686A1 (ko) |
JP (1) | JP2009528828A (ko) |
KR (1) | KR20080113223A (ko) |
CN (1) | CN101395182A (ko) |
AU (1) | AU2007222798A1 (ko) |
BR (1) | BRPI0708636A2 (ko) |
CA (1) | CA2638833A1 (ko) |
IL (1) | IL193386A0 (ko) |
MX (1) | MX2008011280A (ko) |
WO (1) | WO2007101441A1 (ko) |
ZA (1) | ZA200806362B (ko) |
Families Citing this family (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004061104A2 (en) | 2003-01-07 | 2004-07-22 | Symphogen A/S | Method for manufacturing recombinant polyclonal proteins |
AU2005263334C1 (en) | 2004-07-20 | 2011-01-20 | Symphogen A/S | A procedure for structural characterization of a recombinant polyclonal protein or a polyclonal cell line |
JP2009518320A (ja) * | 2005-12-05 | 2009-05-07 | シュムフォウエン アクティーゼルスカブ | 抗オルトポックスウイルス組換えポリクローナル抗体 |
EP2032701B1 (en) * | 2006-06-23 | 2013-11-27 | Alethia Biotherapeutics Inc. | Polynucleotides and polypeptides involved in cancer |
KR101676622B1 (ko) | 2007-03-01 | 2016-11-17 | 심포젠 에이/에스 | 재조합 항-표피 성장 인자 수용체 항체 조성물 |
KR20090118993A (ko) | 2007-03-01 | 2009-11-18 | 심포젠 에이/에스 | 동족체 항체 클로닝 방법 |
JP2010534057A (ja) * | 2007-03-06 | 2010-11-04 | シムフォゲン・アクティーゼルスカブ | 呼吸器合胞体ウイルス感染症を治療するための組換え抗体 |
PL2152872T3 (pl) | 2007-05-25 | 2011-03-31 | Symphogen As | Sposób wytwarzania rekombinowanego białka poliklonalnego |
JP2008289483A (ja) * | 2007-05-25 | 2008-12-04 | Symphogen As | 真核生物系において発現可能な形質転換体のスクリーニング |
MX2010002044A (es) * | 2007-09-07 | 2010-03-18 | Symphogen As | Metodos para produccion recombinante de anticuerpos anti-virus sincitial respiratorio (anti-rsv). |
EP2201040A1 (en) * | 2007-09-24 | 2010-06-30 | Vanderbilt University | Monoclonal antibodies to respiratory syncytial virus and uses thereof |
BRPI0819210A2 (pt) * | 2007-10-25 | 2015-06-23 | Trellis Bioscience Inc | Anticorpos de proteína g anti-rsv |
WO2010022736A2 (en) | 2008-08-29 | 2010-03-04 | Symphogen A/S | Recombinant anti-epidermal growth factor receptor antibody compositions |
KR20110081284A (ko) * | 2008-10-06 | 2011-07-13 | 심포젠 에이/에스 | 조합 약물 제품에 대한 약물 후보물질의 동정방법 및 선택방법 |
AU2009321508B2 (en) | 2008-11-03 | 2015-03-12 | Adc Therapeutics Sa | Antibodies that specifically block the biological activity of a tumor antigen |
US8748103B2 (en) * | 2008-11-07 | 2014-06-10 | Sequenta, Inc. | Monitoring health and disease status using clonotype profiles |
US9528160B2 (en) | 2008-11-07 | 2016-12-27 | Adaptive Biotechnolgies Corp. | Rare clonotypes and uses thereof |
SG195652A1 (en) * | 2008-11-07 | 2013-12-30 | Sequenta Inc | Methods of monitoring conditions by sequence analysis |
US9506119B2 (en) | 2008-11-07 | 2016-11-29 | Adaptive Biotechnologies Corp. | Method of sequence determination using sequence tags |
US8628927B2 (en) | 2008-11-07 | 2014-01-14 | Sequenta, Inc. | Monitoring health and disease status using clonotype profiles |
US8691510B2 (en) * | 2008-11-07 | 2014-04-08 | Sequenta, Inc. | Sequence analysis of complex amplicons |
US9365901B2 (en) | 2008-11-07 | 2016-06-14 | Adaptive Biotechnologies Corp. | Monitoring immunoglobulin heavy chain evolution in B-cell acute lymphoblastic leukemia |
ES2726702T3 (es) | 2009-01-15 | 2019-10-08 | Adaptive Biotechnologies Corp | Perfilado de la inmunidad adaptativa y métodos para la generación de anticuerpos monoclonales |
JP2012531202A (ja) | 2009-06-25 | 2012-12-10 | フレッド ハチンソン キャンサー リサーチ センター | 適応免疫を測定する方法 |
KR101435953B1 (ko) * | 2009-07-17 | 2014-09-02 | 한림대학교 산학협력단 | 리포좀에 포집된 올리고뉴클레오타이드 및 에피토프를 포함하는 면역증강용 조성물 |
MX2012003538A (es) | 2009-10-09 | 2012-08-03 | Symphogen As | Cuantificacion multiple de proteinas recombinantes individuales en una mezcla mediante peptidos distintivos y espectrometria de masas. |
US9043160B1 (en) | 2009-11-09 | 2015-05-26 | Sequenta, Inc. | Method of determining clonotypes and clonotype profiles |
CN106188284B (zh) * | 2010-07-09 | 2020-05-08 | 扬森疫苗与预防公司 | 抗人呼吸道合胞病毒(rsv)抗体以及使用方法 |
WO2012048340A2 (en) * | 2010-10-08 | 2012-04-12 | President And Fellows Of Harvard College | High-throughput immune sequencing |
EP2663334A4 (en) * | 2011-01-10 | 2016-01-13 | Univ Emory | ANTIBODIES AGAINST INFLUENZA |
CA2888908A1 (en) | 2011-03-31 | 2012-10-04 | Alethia Biotherapeutics Inc. | Antibodies against kidney associated antigen 1 and antigen binding fragments thereof |
US10385475B2 (en) | 2011-09-12 | 2019-08-20 | Adaptive Biotechnologies Corp. | Random array sequencing of low-complexity libraries |
EP2768982A4 (en) | 2011-10-21 | 2015-06-03 | Adaptive Biotechnologies Corp | QUANTIFICATION OF ADAPTIVE IMMUNOCELL GENOMES IN A COMPLEX MIX OF CELLS |
US9824179B2 (en) | 2011-12-09 | 2017-11-21 | Adaptive Biotechnologies Corp. | Diagnosis of lymphoid malignancies and minimal residual disease detection |
US9499865B2 (en) | 2011-12-13 | 2016-11-22 | Adaptive Biotechnologies Corp. | Detection and measurement of tissue-infiltrating lymphocytes |
PT2802351T (pt) | 2012-01-09 | 2019-06-27 | Adc Therapeutics Sa | Agentes para o tratamento de cancro da mama triplo negativo |
WO2013119419A1 (en) * | 2012-02-08 | 2013-08-15 | North Carolina State University | Treatment of allergic diseases with recombinant antibodies |
US10077478B2 (en) | 2012-03-05 | 2018-09-18 | Adaptive Biotechnologies Corp. | Determining paired immune receptor chains from frequency matched subunits |
WO2013169957A1 (en) | 2012-05-08 | 2013-11-14 | Adaptive Biotechnologies Corporation | Compositions and method for measuring and calibrating amplification bias in multiplexed pcr reactions |
EA032908B1 (ru) * | 2012-08-23 | 2019-08-30 | Эдженсис, Инк. | Конъюгаты антитело-лекарственное средство (adc), которые связываются с белками 158p1d7 |
AU2013327423B2 (en) | 2012-10-01 | 2017-06-22 | Adaptive Biotechnologies Corporation | Immunocompetence assessment by adaptive immune receptor diversity and clonality characterization |
EP2917360B1 (en) | 2012-11-06 | 2020-01-08 | Medlmmune, LLC | Antibodies to s. aureus surface determinants |
TWI659968B (zh) | 2013-03-14 | 2019-05-21 | 再生元醫藥公司 | 針對呼吸道融合病毒f蛋白質的人類抗體及其使用方法 |
CA2906076A1 (en) | 2013-03-15 | 2014-09-18 | Abvitro, Inc. | Single cell bar-coding for antibody discovery |
CN103196731A (zh) * | 2013-04-18 | 2013-07-10 | 王刚平 | 用于鉴别乳腺肌上皮病变的多重染色试剂及其检测方法 |
US9708657B2 (en) | 2013-07-01 | 2017-07-18 | Adaptive Biotechnologies Corp. | Method for generating clonotype profiles using sequence tags |
CA2941612A1 (en) | 2014-03-05 | 2015-09-11 | Adaptive Biotechnologies Corporation | Methods using randomer-containing synthetic molecules |
US10066265B2 (en) | 2014-04-01 | 2018-09-04 | Adaptive Biotechnologies Corp. | Determining antigen-specific t-cells |
ES2777529T3 (es) | 2014-04-17 | 2020-08-05 | Adaptive Biotechnologies Corp | Cuantificación de genomas de células inmunitarias adaptativas en una mezcla compleja de células |
SG10201911069WA (en) | 2014-09-15 | 2020-01-30 | Abvitro Llc | High-throughput nucleotide library sequencing |
BR112017006598A2 (pt) * | 2014-09-30 | 2018-04-17 | Neurimmune Holding Ag | anticorpo de repetições antidipeptídeo derivado de ser humano (dprs) |
EA201790558A1 (ru) * | 2014-10-15 | 2017-08-31 | Ксенотера | Композиция с пониженной иммуногенностью |
US10392663B2 (en) | 2014-10-29 | 2019-08-27 | Adaptive Biotechnologies Corp. | Highly-multiplexed simultaneous detection of nucleic acids encoding paired adaptive immune receptor heterodimers from a large number of samples |
US10246701B2 (en) | 2014-11-14 | 2019-04-02 | Adaptive Biotechnologies Corp. | Multiplexed digital quantitation of rearranged lymphoid receptors in a complex mixture |
WO2016086029A1 (en) | 2014-11-25 | 2016-06-02 | Adaptive Biotechnologies Corporation | Characterization of adaptive immune response to vaccination or infection using immune repertoire sequencing |
US11047008B2 (en) | 2015-02-24 | 2021-06-29 | Adaptive Biotechnologies Corporation | Methods for diagnosing infectious disease and determining HLA status using immune repertoire sequencing |
US11041202B2 (en) | 2015-04-01 | 2021-06-22 | Adaptive Biotechnologies Corporation | Method of identifying human compatible T cell receptors specific for an antigenic target |
WO2018052789A1 (en) * | 2016-09-08 | 2018-03-22 | Pcm Targetech, Llc | Monoclonal antibodies specific to the plexin-semaphorin-integrin (psi) domain of ron for drug delivery and its application in cancer therapy |
US10428325B1 (en) | 2016-09-21 | 2019-10-01 | Adaptive Biotechnologies Corporation | Identification of antigen-specific B cell receptors |
EP3538558A4 (en) | 2016-11-09 | 2020-07-15 | North Carolina State University | TREATMENT OF ALLERGIC DISEASES WITH A CHIMERAL PROTEIN |
US11254980B1 (en) | 2017-11-29 | 2022-02-22 | Adaptive Biotechnologies Corporation | Methods of profiling targeted polynucleotides while mitigating sequencing depth requirements |
WO2019165019A1 (en) * | 2018-02-21 | 2019-08-29 | Vanderbilt University | Antibodies to human respiratory syncytial virus protein f pre-fusion conformation and methods of use therefor |
SG11202111744UA (en) * | 2019-04-30 | 2021-11-29 | Gigagen Inc | Recombinant polyclonal proteins and methods of use thereof |
CR20230388A (es) * | 2021-01-29 | 2023-10-05 | Amgen Inc | Materiales y métodos para el seguimiento del cáncer mediante la administración de un anticuerpo anti-mcl1 |
CN113249333B (zh) * | 2021-03-16 | 2023-06-02 | 贵州省人民医院 | 一种分泌抗呼吸道合胞病毒单克隆抗体的杂交瘤细胞株rsvn4c3 |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4767610A (en) * | 1984-10-19 | 1988-08-30 | The Regents Of The University Of California | Method for detecting abnormal cell masses in animals |
US5639853A (en) * | 1987-09-29 | 1997-06-17 | Praxis Biologics, Inc. | Respiratory syncytial virus vaccines |
JP2631767B2 (ja) * | 1990-07-19 | 1997-07-16 | アメリカ合衆国 | ウイルス性呼吸器系疾患の予防または治療のためのエーロゾル |
US5344640A (en) * | 1991-10-22 | 1994-09-06 | Mallinckrodt Medical, Inc. | Preparation of apatite particles for medical diagnostic imaging |
US5824307A (en) * | 1991-12-23 | 1998-10-20 | Medimmune, Inc. | Human-murine chimeric antibodies against respiratory syncytial virus |
DE69332643T2 (de) * | 1992-09-16 | 2003-11-27 | Scripps Research Inst | Menschliche, neutralisierende, monoklonale antikörper gegen das respiratorische synzytialvirus |
FR2718452B1 (fr) * | 1994-04-06 | 1996-06-28 | Pf Medicament | Elément d'immunogène, agent immunogène, composition pharmaceutique et procédé de préparation. |
EP0777685B1 (en) * | 1994-08-25 | 1999-04-14 | Stichting Instituut voor Dierhouderij en Diergezondheid | Antigenic peptides derived from the g protein of rsv for type- and subtype-specific diagnosis of respiratory syncytial virus (rsv) infection |
US5922344A (en) * | 1995-02-10 | 1999-07-13 | Abbott Laboratories | Product for prevention of respiratory virus infection and method of use |
US5811524A (en) * | 1995-06-07 | 1998-09-22 | Idec Pharmaceuticals Corporation | Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof |
US20020141990A1 (en) * | 1996-11-01 | 2002-10-03 | Smithkline Beecham Corporation | Anti-RSV human monoclonal antibodies |
US6699478B1 (en) * | 1997-09-19 | 2004-03-02 | Wyeth Holdings Corporation | Enhanced immune response to attachment (G) protein of Respiratory Syncytial Virus |
JP4992068B2 (ja) * | 2000-01-27 | 2012-08-08 | メディミューン,エルエルシー | 超高親和性中和抗体 |
AU2001240020B9 (en) * | 2000-03-01 | 2008-12-04 | Medimmune, Llc | High potency recombinant antibodies and method for producing them |
US20050175986A1 (en) * | 2000-05-09 | 2005-08-11 | Smit Kline Beecham Corporation | Human monoclonal antibody |
CA2426312C (en) * | 2000-10-18 | 2014-01-14 | Ralph A. Tripp | Compositions and methods for modulating rsv infection and immunity |
US6818216B2 (en) * | 2000-11-28 | 2004-11-16 | Medimmune, Inc. | Anti-RSV antibodies |
JP2005533861A (ja) * | 2002-07-25 | 2005-11-10 | メデュームン,インコーポレーテッド | 抗RSV、抗hMPV、および抗PIV抗体を使用するRSV、hMPV、およびPIVの治療法と予防法 |
WO2004061104A2 (en) * | 2003-01-07 | 2004-07-22 | Symphogen A/S | Method for manufacturing recombinant polyclonal proteins |
US20060275766A1 (en) * | 2003-01-07 | 2006-12-07 | Haurum John S | Method for manufacturing recombinant polyclonal proteins |
US6821450B2 (en) * | 2003-01-21 | 2004-11-23 | Hewlett-Packard Development Company, L.P. | Substrate and method of forming substrate for fluid ejection device |
AU2004226369A1 (en) * | 2003-03-28 | 2004-10-14 | Medimmune, Llc | Compositions and methods involving respiratory syncytial virus subgroup B strain 9320 |
US7070786B2 (en) * | 2003-06-06 | 2006-07-04 | Centocor, Inc. | RSV proteins, antibodies, compositions, methods and uses |
TWI333977B (en) * | 2003-09-18 | 2010-12-01 | Symphogen As | Method for linking sequences of interest |
WO2006034292A2 (en) * | 2004-09-21 | 2006-03-30 | Medimmune, Inc. | Antibodies against and methods for producing vaccines for respiratory syncytial virus |
JP2009518320A (ja) * | 2005-12-05 | 2009-05-07 | シュムフォウエン アクティーゼルスカブ | 抗オルトポックスウイルス組換えポリクローナル抗体 |
JP2010534057A (ja) * | 2007-03-06 | 2010-11-04 | シムフォゲン・アクティーゼルスカブ | 呼吸器合胞体ウイルス感染症を治療するための組換え抗体 |
WO2009048769A2 (en) * | 2007-10-10 | 2009-04-16 | Kirin Pharma Kabushiki Kaisha | Vaccinia virus h3l and b5r specific monoclonal antibodies and methods of making and using same |
-
2007
- 2007-03-06 MX MX2008011280A patent/MX2008011280A/es not_active Application Discontinuation
- 2007-03-06 KR KR1020087024416A patent/KR20080113223A/ko not_active Application Discontinuation
- 2007-03-06 EP EP07711256A patent/EP2004686A1/en not_active Withdrawn
- 2007-03-06 BR BRPI0708636-9A patent/BRPI0708636A2/pt not_active IP Right Cessation
- 2007-03-06 CN CNA2007800077783A patent/CN101395182A/zh active Pending
- 2007-03-06 CA CA002638833A patent/CA2638833A1/en not_active Abandoned
- 2007-03-06 US US11/792,927 patent/US20100040606A1/en not_active Abandoned
- 2007-03-06 AU AU2007222798A patent/AU2007222798A1/en not_active Abandoned
- 2007-03-06 WO PCT/DK2007/000113 patent/WO2007101441A1/en active Application Filing
- 2007-03-06 JP JP2008557594A patent/JP2009528828A/ja not_active Withdrawn
-
2008
- 2008-07-22 ZA ZA200806362A patent/ZA200806362B/xx unknown
- 2008-08-12 IL IL193386A patent/IL193386A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
IL193386A0 (en) | 2011-08-01 |
BRPI0708636A2 (pt) | 2011-06-07 |
AU2007222798A1 (en) | 2007-09-13 |
JP2009528828A (ja) | 2009-08-13 |
WO2007101441A1 (en) | 2007-09-13 |
CA2638833A1 (en) | 2007-09-13 |
MX2008011280A (es) | 2008-09-12 |
US20100040606A1 (en) | 2010-02-18 |
CN101395182A (zh) | 2009-03-25 |
EP2004686A1 (en) | 2008-12-24 |
KR20080113223A (ko) | 2008-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200806362B (en) | Recombinant polyclonal antibody for treatment of respiratory syncytial virus infections | |
IL200330A0 (en) | Recombinant antibodies for treatment of respiratory syncytial virus infections | |
ZA201000756B (en) | Methods for recombinant manufacturing of anti-rsv antibodies | |
HK1151535A1 (en) | Monoclonal antibodies against claudin-18 for treatment of cancer -18 | |
LT1951272T (lt) | Lactobacillus panaudojimas virusinių infekcijų gydymui | |
IL226348A0 (en) | An oligosaccharide compound for the treatment of urinary tract infections | |
EP2120566A4 (en) | COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF VIRUS INFECTIONS | |
IL212633A (en) | A monoclonal antibody or its antigen-binding portion, its pharmaceutical preparations and its use in the preparation of cancer drugs | |
IL223424B (en) | Anti-human respiratory syncytial virus (rsv) antibodies and methods of use | |
HK1156038A1 (en) | Compounds and pharmaceutical compositions for the treatment of viral infections | |
ZA201102112B (en) | Monoclonal anti-claudin 1 antibodies for the inhibition of hepatitis c virus infection | |
PL2018184T3 (pl) | Przeciwciało Anty-VEGF-B do stosowania w leczeniu lub profilaktyce cukrzycy typu II lub zespołu metabolicznego | |
HK1144794A1 (en) | Devices for treatment of viral infections | |
BRPI0915960A2 (pt) | antígenos de polipeptídeos do vírus sincicial respiratório qimérico | |
IL195272A0 (en) | Methods and compositions for the treatment of viral infections | |
DK2229409T3 (da) | Fremgangsmåde til at forøge den terapeutiske effektivitet af immunoglobulin-G-klasse-3-(IgG3)-antistoffer | |
GB2467491B (en) | Humanized anti-Venezuelan equine encephalitis virus recombinant antibodies | |
ZA201403564B (en) | Monoclonal antibodies specific for the m2-1 antigen of respiratory syncytial virus (rsv) | |
IL197783A0 (en) | Polycyclic agents for the treatment of respiratory syncytial virus infections | |
IL221320A0 (en) | Compounds for treating respiratory syncytial virus infections | |
DK1847256T3 (da) | Antibakterielle sammensætninger til behandling af infektioner i de øvre og nedre luftveje | |
ZA200904068B (en) | Anti-tsg101 antibodies and their uses for treatment of viral infections | |
BRPI0923569A2 (pt) | anticorpo monoclonal anti-hcv como um medicamento para tratamento e prevenção de infecções por hcv | |
PL2132215T3 (pl) | Związki do zapobiegania lub leczenia zakażeń wirusowych i sposoby ich stosowania | |
TH137774B (th) | การใช้แอซิโธรไมซินสำหรับการผลิตเภสัชภัณฑ์สำหรับรักษาการติดเชื้อของลูกตา |